Back to Screener

Healthcare

Immatics N.V.(IMTX)

Live Price

Offline

$9.54

-4.84% today

1Y Change

+68.69%

Window

Jun 26, 2025 β†’ Jun 15, 2026

Market Cap
$1.26B
Revenue Growth
-69.0%
EPS Growth
-1200.0%
Dividend Yield
0.0%

Coverage: 243 bars Β· Jun 26, 2025 β†’ Jun 15, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Immatics N.V. (IMTX) is a Healthcare stock with a market cap of $1.26B and listed on NASDAQ. The stock last traded around $9.54 and up 68.7% across the available one-year price window (Jun 26, 2025 β†’ Jun 15, 2026). Baseline metrics include revenue growth of -69.0%, EPS growth of -1200.0%, a dividend yield of 0.0%. What stands out right now is revenue -69.0%, EPS -1200.0%, free cash flow -0.8% with operating margin -371.6% and ROIC -34.0%. Valuation already assumes a fairly strong business story at price/sales 26.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines IMTX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

IMTX vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

IMTX

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

IMTX Max Drawdown

-27.80%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for IMTX and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
May 12, 26
β€”
Est -0.42
β€”
β€”
Est 12241.7B
β€”
May 12
β€”
Mar 5, 26
βœ“
-0.34
Est -0.48
+29.2%
22315.7B
Est 11261.5B
+98.2%
Mar 5
β€”
Nov 17, 25
βœ—
-0.49
Est -0.44
-11.5%
6075.3B
Est 10706.5B
-43.3%
Nov 17
β€”
Aug 13, 25
βœ—
-0.66
Est -0.38
-73.7%
5577.5B
Est 12527.3B
-55.5%
Aug 13
β€”
May 13, 25
βœ“
-0.35
Est -0.39
+10.3%
20370.5B
Est 13509.0B
+50.8%
May 13
β€”
Mar 27, 25
βœ“
0.48
Est -0.33
+245.4%
58248.4B
Est 23717.0B
+145.6%
Mar 27
β€”
Nov 18, 24
βœ“
-0.12
Est -0.27
+55.6%
55449.6B
Est 16156.4B
+243.2%
Nov 18
β€”
Aug 13, 24
βœ“
-0.18
Est -0.35
+48.6%
20166.1B
Est 14900.0B
+35.3%
Aug 13
β€”
May 14, 24
βœ“
-0.04
Est -0.74
+94.6%
32708.8B
Est 22000.0B
+48.7%
May 14
β€”
Mar 21, 24
βœ“
-0.32
Est -0.41
+21.9%
17509.3B
Est 16370.0B
+7.0%
Mar 21
β€”
Nov 14, 23
βœ“
-0.35
Est -0.42
+16.7%
6251.0B
Est 15240.0B
-59.0%
Nov 14
β€”
Aug 17, 23
βœ—
-0.35
Est -0.34
-2.9%
24386.2B
Est 22270.0B
+9.5%
Aug 17
β€”
May 16, 23
βœ“
-0.28
Est -0.35
+20.0%
10650.3B
Est 12950.2B
-17.8%
May 16
β€”
Mar 21, 23
βœ—
-0.23
Est 0.17
-235.3%
40553.2B
Est 22690.0B
+78.7%
Mar 21
β€”
Nov 17, 22
βœ—
-0.32
Est -0.31
-3.2%
14707.2B
Est β€”
β€”
Nov 17
β€”
Aug 9, 22
βœ—
-0.23
Est 0.13
-276.9%
18007.2B
Est 25344.8B
-28.9%
Aug 9
β€”
Jun 2, 22
βœ—
1.35
Est 1.76
-23.3%
113828.0B
Est 158373.0B
-28.1%
Jun 2
β€”
Mar 23, 22
βœ—
-0.30
Est 1.94
-115.5%
17829.9B
Est 10741.2B
+66.0%
Mar 23
β€”
Nov 16, 21
βœ—
-0.51
Est -0.31
-64.5%
7478.3B
Est 11942.7B
-37.4%
Nov 16
β€”
Aug 10, 21
βœ—
-0.46
Est -0.38
-21.1%
6156.5B
Est 10010.8B
-38.5%
Aug 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener